AffRegInc.i
Checkpoint
PascalFrancis
Racine
Checkpoint
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PascalFrancis)

Index « AffRegInc.i » - entrée « Osaka University »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Osaka < Osaka University < Osaka, 565-0871  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000227 (2009) Toshio Tanaka [Japon] ; Yusuke Kuwahara [Japon] ; Yoshihito Shima [Japon] ; Toru Hirano [Japon] ; Mari Kawai [Japon] ; Masako Ogawa [Japon] ; Junsuke Arimitsu [Japon] ; Keisuke Hagihara [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Ichiro Kawase [Japon] ; Tadamitsu Kishimoto [Japon]Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab
000230 (2009) N. Nishimoto [Japon] ; N. Miyasaka [Japon] ; K. Yamamoto [Japon] ; S. Kawai [Japon] ; T. Takeuchi [Japon] ; J. Azuma [Japon]Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
000238 (2008) Norihiro Nishimoto [Japon] ; Hideko Nakahara [Japon] ; Naoko Yoshio-Hoshino [Japon] ; Toru Mima [Japon]Successful Treatment of a Patient With Takayasu Arteritis Using a Humanized Anti-Interleukin-6 Receptor Antibody
000251 (2007) Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Norikazu Murata [Japon] ; Désirée Van Der Heijde [Pays-Bas] ; Tadamitsu Kishimoto [Japon]Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAL) : evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
000258 (2006) R. N. Maini [Royaume-Uni] ; P. C. Taylor [Royaume-Uni] ; J. Szechinski [Pologne] ; K. Pavelka [République tchèque] ; J. Bröll [Autriche] ; G. Balint [Hongrie] ; P. Emery [Royaume-Uni] ; F. Raemen [Belgique] ; J. Petersen [Danemark] ; J. Smolen [Autriche] ; D. Thomson [Royaume-Uni] ; T. Kishimoto [Japon]Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/AffRegInc.i -k "Osaka University" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/AffRegInc.i  \
                -Sk "Osaka University" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Osaka University
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021